Results of Phase I/II VMAT-TMI Dose Escalation Study Of Patients Undergoing Second Allogeneic Stem Cell Transplantation

To report our clinical experience of a dose escalation study using total marrow irradiation (TMI) with volumetric arc therapy (VMAT) as a part of conditioning regimen in a Phase I/II study of patients with hematologic malignancies receiving second allogeneic stem cell transplantation (allo-SCT). From December 2015 to November 2019, eighteen patients with hematologic malignancies undergoing second allo-SCT were treated with Linac based VMAT...